Paul Conrad
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Retinal Diseases and Treatments 13
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 1
- Co-authors
- Dana Beitner‐Johnson (8 shared papers)David E. Millhorn (8 shared papers)Thomas L. Freeman (2 shared papers)Jiahuai Han (1 shared paper)Laura Conforti (3 shared papers)Karen A. Seta (2 shared papers)S Kobayashi (1 shared paper)Shuichi Kobayashi (1 shared paper)
- Journals
- JAMA Ophthalmology (5 papers)Ophthalmology (3 papers)Advances in experimental medicine and biology (2 papers)Journal of Biological Chemistry (2 papers)Ophthalmology Retina (2 papers)
- Partner nations
- United States
In The Last Decade
Paul Conrad
20 papers receiving 831 citations
Paul Conrad's Hit Papers
Peers
Comparison fields: 5 of 73
- Ophthalmology 343
- Cancer Research 229
- Radiology, Nuclear Medicine and Imaging 139
- Endocrine and Autonomic Systems 38
- Molecular Biology 324
Countries citing papers authored by Paul Conrad
This map shows the geographic impact of Paul Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Conrad more than expected).
Fields of papers citing papers by Paul Conrad
This network shows the impact of papers produced by Paul Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Conrad. The network helps show where Paul Conrad may publish in the future.
Co-authors
The 12 scholars most cited alongside Paul Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 180 | |
| 2 | 1999 | 167 | |
| 3 | 1999 | 156 | |
| 4 | Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial Hit paper breakdown → | 2024 | 71 |
| 5 | 2014 | 46 | |
| 6 | 2002 | 34 | |
| 7 | 2018 | 32 | |
| 8 | 2001 | 31 | |
| 9 | 1999 | 25 | |
| 10 | 2021 | 22 | |
| 11 | 2022 | 17 | |
| 12 | 2023 | 17 | |
| 13 | 2001 | 14 | |
| 14 | 2002 | 12 | |
| 15 | 2000 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 5 | |
| 19 | Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration | 2008 | 4 |
| 20 | 2023 | 3 |
About Paul Conrad
Paul Conrad is a scholar working on Ophthalmology, Cancer Research, Endocrine and Autonomic Systems, Cell Biology and Molecular Biology, having authored 21 papers that have together received 860 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (13 papers), Melanoma and MAPK Pathways (3 papers), Hemoglobin structure and function (2 papers), Mitochondrial Function and Pathology (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Neuroscience of respiration and sleep (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Ophthalmology (343 citations), Cancer Research (229 citations), Radiology, Nuclear Medicine and Imaging (139 citations), Endocrine and Autonomic Systems (38 citations) and Molecular Biology (324 citations). Paul Conrad has collaborated with scholars based in United States. Frequent co-authors include Dana Beitner‐Johnson, David E. Millhorn, Thomas L. Freeman, Jiahuai Han, Laura Conforti, Karen A. Seta, S Kobayashi, Shuichi Kobayashi, Richard H. Kim and Yong Yuan. Their work appears in journals such as JAMA Ophthalmology, Ophthalmology, Advances in experimental medicine and biology, Journal of Biological Chemistry and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.